Home Data Calendar Blog

KPTI

Tables

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Common Stock Value 0.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.000.000.000.000.000.000.000.000.000.000.000.00NANANANANANANA
dei: Entity Common Stock Shares Outstanding NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Weighted Average Number Of Share Outstanding Basic And Diluted NANANANANANA77.57NA75.4675.190.07NA0.070.070.07NA62.0960.9360.86NA60.5956.0949.60NA47.1445.8341.89NA36.8235.96NA35.7135.70NA32.5629.6629.61NA-0.002.402.23NA-0.00NANA
Earnings Per Share Basic And Diluted NANANANANANA-0.530.52-0.69-0.71-0.77-0.58-0.73-0.63-0.78-0.76-0.67-0.71-1.09-0.96-0.79-0.60-0.78-0.80-0.65-0.64-0.71-0.65-0.69-0.84-0.81-0.85-0.92-0.79-0.61-0.55-0.46-0.722544587.00-2.86-2.52-2.081846859.00-2.37-2.71

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Revenue From Contract With Customer Excluding Assessed Tax 36.0137.5838.7033.5836.1539.6847.67126.2737.6922.6023.2635.1021.3333.5118.1418.1013.159.490.150.210.2419.8910.001.530.000.000.070.050.050.060.030.070.150.020.020.020.170.020.000.130.230.030.030.530.03
Operating Expenses 67.2767.1569.6067.4566.9882.5982.2679.3181.5071.6575.6372.1768.4473.8365.4961.3652.5551.1865.0857.6649.3954.2248.9440.9931.0529.7530.3527.2125.7930.5429.3330.6833.1625.9619.7716.4713.8812.179.327.005.844.273.674.574.02
Operating Costs And Expenses NANANANANANA1.430.740.591.140.931.050.440.400.821.391.01NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Research And Development Expense 35.5531.4832.3430.9331.3644.3142.0644.0045.8133.9837.0537.1937.0442.5934.0031.5826.2726.5237.9738.8936.4344.7341.3234.8325.2423.1224.0820.6719.8924.5824.0625.9227.0120.0415.9513.1610.989.697.746.064.963.673.00NANA
Selling General And Administrative Expense 30.8034.4835.9134.6534.6537.3438.7734.5635.1036.5337.6533.9330.9730.8430.6828.3925.2724.6627.1018.7712.97NANANANANANANANANANANANANANANANANANANANANANANANA
Operating Income Loss -31.26-29.57-30.90-33.87-30.84-42.91-34.5946.96-43.81-49.05-52.37-37.07-47.11-40.32-47.36-43.27-39.40-41.69-64.92-57.45-49.15-34.33-38.94-39.45-31.05-29.75-30.28-27.16-25.74-30.48-29.30-30.61-33.01-25.94-19.74-16.45-13.71-12.15-9.32-6.87-5.61-4.24-3.63-4.03-3.98
Interest Expense 6.075.785.765.886.116.316.687.948.015.005.097.076.806.766.516.473.093.093.00NANANANANANANANANANANANANANANANANANANANANANANANANANA
Interest Paid Net 0.00NANA2.590.00NANA2.590.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Allocated Share Based Compensation Expense 5.086.065.396.176.8015.097.346.877.428.137.366.316.516.435.153.553.724.123.91NANANANANANANANANANANANANANANANANANA2.021.32NANA0.320.16NANA
Income Tax Expense Benefit 0.010.130.050.070.040.120.13-0.120.110.130.150.060.040.140.070.000.020.010.010.020.01-0.020.010.010.010.020.02NANANANANANANANANANANANANANANANANANA
Profit Loss -34.51-32.63-34.13-38.51-36.32-49.06-41.4038.72-51.81-53.58-57.41-43.42-53.49-46.43-52.93-48.65-41.37-43.41-66.16-58.21-48.08-33.66-38.46-39.04-30.64NANANANANANANANANANANANANANANANANANANANA
Net Income Loss -34.51-32.63-34.13-38.51-36.32-49.06-41.4038.72-51.81-53.58-57.41-43.42-53.49-46.43-52.93-48.65-41.37-43.41-66.16-58.21-48.08-33.66-38.46-39.04-30.64-29.39-29.92-26.93-25.43-30.16-29.05-30.37-32.70-25.93-19.72-16.43-13.69NANANANANANANANA
Comprehensive Income Net Of Tax -34.47-32.99-33.91-38.39-36.54-49.69-41.5038.54-51.64-53.69-57.63-43.51-53.78-45.12-53.31-48.65-41.46-43.33-65.94-58.30-47.98-33.63-38.53-39.17-30.57-29.35-29.85-27.18-25.59-30.11-29.30-30.25-32.86-25.96-19.72-16.43-13.69-12.15-9.32-6.87-5.61NANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Assets 269.96297.83325.80358.17231.24256.48294.03305.31254.09286.57274.91313.05337.59380.01416.14294.96297.75238.10287.21341.19219.99256.59146.37180.29163.77185.75155.44180.38183.62170.90215.44236.97263.29220.34235.16137.68149.28158.2355.90NANA1.31NANANA
Liabilities 370.36369.08370.97374.83371.52372.82377.11384.98380.07369.70314.55262.50253.82250.21249.99245.19237.88155.63165.93158.0248.9143.1250.8450.8322.6019.0417.0718.1416.6917.3317.0816.3815.9713.547.356.00NA3.29NANANANANANANA
Liabilities And Stockholders Equity 269.96297.83325.80358.17231.24256.48294.03305.31254.09286.57274.91313.05337.59380.01416.14294.96297.75238.10287.21341.19219.99256.59146.37180.29163.77185.75155.44180.38183.62170.90215.44236.97263.29220.34235.16137.68149.28158.2355.90NANA1.31NANANA
Stockholders Equity -100.40-71.25-45.17-16.66-140.28-116.34-83.08-79.67-125.98-83.13-39.6450.5583.77129.80166.1549.7759.8782.47121.28183.17171.08213.4795.53129.46141.18166.71138.36162.24166.93153.57198.37220.59247.33206.79227.80131.68144.10154.93-47.78NANA-27.88NANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Assets Current 263.22291.38318.54350.16222.68242.45276.53275.61241.58273.50255.51276.53285.45317.84370.92278.57280.87222.83271.44334.61211.56244.56133.31148.42121.68145.72112.23131.64130.25124.20177.60198.34225.25207.75231.35135.28147.57157.9653.59NANA0.95NANANA
Cash And Cash Equivalents At Carrying Value 43.6680.8984.06135.1971.3582.25153.26190.46137.40141.3188.4785.9282.30103.10202.25128.86168.0075.5583.51118.02101.60118.9737.5069.0054.4555.3825.5849.6643.9137.7258.3643.5024.23150.61227.13132.31144.89155.9752.9317.670.760.391.87NANA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 44.5881.8585.54136.8873.0684.03154.91197.44140.44142.7190.0089.1284.11105.73203.95130.69168.7276.2684.22118.74102.31119.6037.7969.4954.9455.8726.0650.14NANA58.84NANANANANANANANANANANANANANA
Receivables Net Current 37.9232.2835.2047.0927.4523.4824.9922.5018.7517.8917.8412.8811.069.589.287.86NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Inventory Net 3.103.673.834.224.253.473.874.113.943.903.112.642.011.650.970.350.10NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Inventory Finished Goods 0.760.850.940.980.990.340.390.410.400.220.110.080.450.300.150.070.10NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Inventory Raw Materials And Supplies 0.391.121.121.370.260.262.561.801.711.822.221.92NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Assets Current NANANANA31.4732.0829.141.53NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Prepaid Expense And Other Assets Current 13.3318.1018.2819.82NANANA14.0412.2715.069.379.298.247.977.557.295.315.677.016.414.793.442.401.752.082.072.152.083.441.461.973.114.072.034.212.982.671.980.66NANA0.56NANANA
Available For Sale Securities Debt Securities 164.66155.87176.32142.7877.0388.6052.0538.1668.8296.59143.57187.54220.11242.47181.26135.11101.55141.61180.92212.18NANANA106.87NANANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Property Plant And Equipment Gross NANANA7.78NANANA7.70NANANA7.41NANANA7.29NANANA7.166.015.525.184.744.694.684.684.684.664.664.614.614.023.253.101.040.710.590.56NANA0.53NANANA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment NANANA6.64NANANA6.06NANANA5.19NANANA4.24NANANA3.293.102.912.732.562.382.212.031.841.671.491.130.950.780.490.360.430.390.350.31NANA0.21NANANA
Property Plant And Equipment Net 0.690.770.851.141.251.401.541.641.571.751.982.222.362.592.813.053.243.383.623.862.912.612.452.192.302.472.652.842.993.173.483.663.232.752.730.600.320.240.25NANA0.33NANANA
Available For Sale Debt Securities Amortized Cost Basis 165.10156.48176.64143.1277.3688.7852.0738.16NANANA187.26NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Liabilities Current 62.0858.9361.5565.9161.7662.5466.3473.7268.8758.1262.0160.2052.6350.5749.7046.3539.2032.1743.8646.9041.5736.5446.7349.4721.1617.5215.4816.4814.9515.5215.1314.4414.1012.306.235.655.013.294.00NANA1.93NANANA
Accounts Payable Current 0.942.299.042.770.811.693.441.600.882.313.044.452.421.891.690.983.071.112.274.332.243.794.955.671.893.254.254.752.194.063.814.574.476.292.103.463.271.741.75NANA1.08NANANA
Other Accrued Liabilities Current NANANA6.41NANANA5.60NANANA4.15NANANA3.58NANANA1.560.240.550.280.290.300.270.270.550.620.360.300.380.240.310.590.080.350.150.17NANA0.13NANANA
Accrued Liabilities Current 55.7151.8147.0358.4155.7256.3758.3769.1264.7053.2155.6152.9346.5945.9843.7840.8832.4227.8028.8732.4929.1622.9721.5521.4517.7112.8810.7411.3612.3111.1111.029.479.335.833.652.001.551.171.92NANA0.76NANANA
Other Liabilities Current 2.231.752.501.852.461.862.060.681.120.521.360.611.470.631.220.501.080.450.700.330.560.230.330.130.200.080.210.080.170.080.100.200.100.060.330.130.140.300.33NANA0.02NANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Other Liabilities Noncurrent 1.432.441.08NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Operating Lease Liability Noncurrent 3.674.505.316.106.867.588.298.979.6310.2010.7511.2911.8012.2812.7513.2013.6414.0514.46NANANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Stockholders Equity -100.40-71.25-45.17-16.66-140.28-116.34-83.08-79.67-125.98-83.13-39.6450.5583.77129.80166.1549.7759.8782.47121.28183.17171.08213.4795.53129.46141.18166.71138.36162.24166.93153.57198.37220.59247.33206.79227.80131.68144.10154.93-47.78NANA-27.88NANANA
Common Stock Value 0.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.000.000.000.000.000.000.000.000.000.000.000.00NANANANANANANA
Additional Paid In Capital Common Stock 1345.541340.221333.301327.911165.901153.301136.871098.781091.011082.221072.031119.631109.351101.601092.83923.14884.59865.73861.22857.16786.76781.18629.61625.02597.56592.53534.84528.62506.12467.17455.17448.10444.57345.17NANANANANANANANANANANA
Retained Earnings Accumulated Deficit -1445.20-1410.69-1378.07-1343.94-1305.43-1269.11-1220.05-1178.65-1217.37-1165.56-1111.97-1069.61-1026.19-972.70-926.27-873.34-824.69-783.32-739.91-673.75-615.54-567.45-533.80-495.34-456.30-425.66-396.27-366.10-339.17-313.74-256.53-227.48-197.11-138.35NANANA-62.57NANANANANANANA
Accumulated Other Comprehensive Income Loss Net Of Tax -0.74-0.78-0.42-0.64-0.75-0.540.090.190.370.200.300.520.600.89-0.42-0.04-0.030.06-0.03-0.24-0.15-0.26-0.29-0.22-0.09-0.17-0.20-0.27-0.030.14-0.28-0.03-0.14-0.03NANANANANANANANANANANA
Stock Issued During Period Value New Issues NANANA154.685.790.0029.290.000.000.009.90-0.030.000.00161.8031.6314.56NANA-0.00-0.01145.72NANANANANANANANANANANANANANANANANANANANANANANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 5.086.065.396.176.8015.097.346.877.428.137.366.316.516.435.153.553.724.123.913.904.784.444.16NANANANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Net Cash Provided By Used In Operating Activities -29.53-25.70-18.91-26.84-28.37-35.14-59.2025.48-23.95-55.75-52.89-30.63-44.31-40.28-45.01-39.49-36.51-48.20-66.62-48.17-38.66-37.63-34.65-5.54-21.75NANANANANANANANANANANANANANANANANANANANA
Net Cash Provided By Used In Investing Activities -7.6821.17-32.39-65.3011.67-36.60-14.0430.7721.4346.4643.1931.4021.43-60.03-46.48-33.5240.1739.8031.99-103.1120.57-27.602.48-2.9020.59NANANANANANANANANANANANANANANANANANANANA
Net Cash Provided By Used In Financing Activities 0.00NANA155.845.801.3130.780.900.0262.0610.683.971.242.05164.8334.9488.820.400.15167.780.77147.130.4322.960.16NANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Net Cash Provided By Used In Operating Activities -29.53-25.70-18.91-26.84-28.37-35.14-59.2025.48-23.95-55.75-52.89-30.63-44.31-40.28-45.01-39.49-36.51-48.20-66.62-48.17-38.66-37.63-34.65-5.54-21.75NANANANANANANANANANANANANANANANANANANANA
Net Income Loss -34.51-32.63-34.13-38.51-36.32-49.06-41.4038.72-51.81-53.58-57.41-43.42-53.49-46.43-52.93-48.65-41.37-43.41-66.16-58.21-48.08-33.66-38.46-39.04-30.64-29.39-29.92-26.93-25.43-30.16-29.05-30.37-32.70-25.93-19.72-16.43-13.69NANANANANANANANA
Profit Loss -34.51-32.63-34.13-38.51-36.32-49.06-41.4038.72-51.81-53.58-57.41-43.42-53.49-46.43-52.93-48.65-41.37-43.41-66.16-58.21-48.08-33.66-38.46-39.04-30.64NANANANANANANANANANANANANANANANANANANANA
Increase Decrease In Accounts Receivable 5.64-2.92-11.890.143.97-1.512.5015.49-10.880.044.961.821.480.301.42-0.07NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Increase Decrease In Inventories -0.57-0.15-0.40-0.030.78-0.40-0.232.85-2.890.950.550.960.360.680.620.25NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Increase Decrease In Accounts Payable -1.34-6.766.271.96-0.88-1.751.840.72-1.43-0.73-1.412.030.530.190.71-2.091.96-1.16-2.022.04-1.55-1.10-0.773.78-1.36-0.98-0.522.60-1.89-0.06-0.33-0.32-2.054.13-1.320.151.53-0.010.020.280.380.02NANANA
Share Based Compensation 5.086.065.396.176.8015.097.346.877.428.137.366.316.516.435.153.553.724.123.913.904.774.444.164.504.875.135.915.135.596.415.343.484.484.592.923.892.852.021.320.240.200.32NANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Net Cash Provided By Used In Investing Activities -7.6821.17-32.39-65.3011.67-36.60-14.0430.7721.4346.4643.1931.4021.43-60.03-46.48-33.5240.1739.8031.99-103.1120.57-27.602.48-2.9020.59NANANANANANANANANANANANANANANANANANANANA
Payments To Acquire Property Plant And Equipment NANANA0.000.040.000.080.21NANANA0.120.000.020.010.050.110.000.051.090.490.400.380.06NANANA0.030.000.010.510.140.600.102.290.320.120.03NANANA0.00NANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Net Cash Provided By Used In Financing Activities 0.00NANA155.845.801.3130.780.900.0262.0610.683.971.242.05164.8334.9488.820.400.15167.780.77147.130.4322.960.16NANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Revenue From Contract With Customer Excluding Assessed Tax 36.0137.5838.7033.5836.1539.6847.67126.2737.6922.6023.2635.1021.3333.5118.1418.1013.159.490.150.210.2419.8910.001.530.000.000.070.050.050.060.030.070.150.020.020.020.170.020.000.130.230.030.030.530.03
Antengene Therapeutics Limited, Other Royalty 0.10NANANA1.001.60NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Antengene Therapeutics Limited, Royalty 0.100.700.701.001.401.000.300.300.200.10NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Menarini License Agreement, Royalty 0.000.400.20NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Other 5.809.1210.412.454.1410.6719.3796.4710.972.421.5314.880.0014.912.080.380.339.490.150.210.24NANANANANANANANANANANANANANANANANANANANANANANANA
Product 30.2128.4628.2931.1332.0129.0128.3029.8026.7220.1821.7320.2221.3318.6016.0617.7212.820.00NANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service, Accounts Receivable1 5.40-2.7011.80NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service, Other Assets NANANANANA4.90NA19.50NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service, Other Current Assets NA1.104.90NA29.7030.40NA1.40NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Net Income Loss
Expenses
Income Tax Expense Benefit
Balance Sheet
Stockholders Equity
Assets
Property Plant And Equipment Net
Current Assets
Inventory Net
NonCurrent Assets
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
Property Plant And Equipment Net
Liabilities
Operating Lease Liability
Current Liabilities
Accounts Payable Current
Noncurrent Liabilities
Other Liabilities Noncurrent
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Nonoperating Income Expense
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Undiscounted Excess Amount
InventoryNet
Inventory Finished Goods

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:MajorCustomers, us-gaap:ProductOrService
(None, 'us-gaap:Royalty')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Major Customers, us-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:MajorCustomers, us-gaap:ProductOrService
('kpti:AntengeneTherapeuticsLimited', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Major Customers, us-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:BalanceSheetLocation
('us-gaap:LicenseAndService', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Balance Sheet Location
us-gaap:OtherIncome
us-gaap:MajorCustomers
(None,)
Other Incomeus-gaap: Major Customers
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FinancialInstrument, us-gaap:InvestmentType
(None, 'us-gaap:ShortTermInvestments')
Available For Sale Securities Debt Securitiesus-gaap: Financial Instrument, us-gaap: Investment Type
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FinancialInstrument, us-gaap:InvestmentType
('us-gaap:FairValueInputsLevel2', None, 'us-gaap:ShortTermInvestments')
Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Financial Instrument, us-gaap: Investment Type
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FinancialInstrument
(None,)
Available For Sale Securities Debt Securitiesus-gaap: Financial Instrument
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FinancialInstrument
('us-gaap:FairValueInputsLevel2', None)
Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Financial Instrument
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
us-gaap:FinancialInstrument, us-gaap:InvestmentType
(None, 'us-gaap:ShortTermInvestments')
Available For Sale Debt Securities Amortized Cost Basisus-gaap: Financial Instrument, us-gaap: Investment Type
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
us-gaap:FinancialInstrument
(None,)
Available For Sale Debt Securities Amortized Cost Basisus-gaap: Financial Instrument
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:MajorCustomers, us-gaap:ProductOrService
(None, 'us-gaap:Royalty')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Major Customers, us-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:MajorCustomers, us-gaap:ProductOrService
('kpti:AntengeneTherapeuticsLimited', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Major Customers, us-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:BalanceSheetLocation
('us-gaap:LicenseAndService', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Balance Sheet Location